Application of machine learning methods in clinical trials for precision medicine

Area of Science:

• Computational Biology and Bioinformatics
• Clinical Trial Design and Methodology
• Precision Medicine and Personalized Therapeutics

Background:

• Effective prediction of patient response to treatments is crucial for precision medicine.
• Current clinical trial designs may not fully optimize treatment assignment for individual patients.
• Integrating advanced algorithms can enhance the efficiency and ethical considerations of clinical trials.

Purpose of the Study:

• To implement machine learning (ML) algorithms within a response-adaptive randomization (RAR) framework.
• To improve patient treatment outcomes by developing predictive models for treatment response.
• To enhance clinical trial design through personalized treatment assignment strategies.

Main Methods:

• Incorporated nine distinct ML algorithms to model the relationship between patient biomarkers and treatment response.
• Developed a predictive model to estimate treatment response rates for new patients.
• Constructed an ensemble model combining the nine ML algorithms to leverage collective predictive power.

Main Results:

• ML-based RAR designs led to more personalized optimal treatment assignments and higher overall response rates in simulations.
• The ensemble ML approach outperformed individual ML methods, achieving the highest response rate.
• The ensemble method also assigned the largest percentage of simulated patients to their optimal treatments.
• Real-world study simulations demonstrated the potential benefits of the proposed ML-based RAR design.

Conclusions:

• ML-based RAR designs offer a promising strategy for assigning patients to personalized, effective treatments.
• This approach enhances the ethical appeal and efficiency of clinical trials, particularly for late-stage cancer patients.
• The findings support the adoption of ML-driven adaptive randomization for optimizing therapeutic strategies in clinical research.